Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

naproxen-esomeprazole

naproxen-esomeprazole
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vimovo DELAYED RELEASE TABLET, ORAL 375 mg-20 mg, 500 mg-20 mg    
Comments:

ORDER FORMULATION

THERAPEUTIC INTERCHANGE

naproxen-esomeprazole (Vimovo)

  • 375 mg-20 mg delayed release tablet BID                                                                              
  • 500 mg-20 mg delayed release tablet BID

naproxen (Anaprox) AND pantoprazole (Protonix)

  • naproxen275 mg tablet oral BID PLUS 40 mg pantoprazole Daily (given separately)
  • naproxen 550 mg tablet oral BID PLUS 40 mg pantoprazole Daily (given separately)

Vimovo medication guide

Reviewed: August 24, 2010

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved